Comments
Description
Transcript
ESR
ESR Erythrocyte Sedimentation Rate alias Sedrate. The basic factors influencing the ESR have been understood since early part of 20th century. The most satisfactory method of performing the test was introduced by Westergren in 1921. Although there is an enormous body of literature concerning the ESR, an elevated value remains a nonspecific finding. The erythrocyte sedimentation rate (ESR) determination is a simple and inexpensive laboratory test that is frequently ordered in clinical medicine. The erythrocyte sedimentation rate (ESR), also called a sedimentation rate or Biernacki Reaction, is the rate at which red blood cells precipitate in a period of 1 hour. It is a common hematology test which is a non-specific measure of inflammation. To perform the test, anticoagulated blood is placed in an upright tube, known as a Westergren tube, and the rate at which the red blood cells fall is measured and reported in mm/h. The test measures the distance that erythrocytes have fallen after one hour in a vertical column of anticoagulated blood under the influence of gravity. The amount of fibrinogen in the blood directly correlates with the ESR. The ESR is governed by the balance between pro-sedimentation factors, mainly fibrinogen, and those factors resisting sedimentation, namely the negative charge of the erythrocytes (zeta potential). When an inflammatory process is present, the high proportion of fibrinogen in the blood causes red blood cells to stick to each other. The red cells form stacks called 'rouleaux' which settle faster. Rouleaux formation can also occur in association with some lymphoproliferative disorders in which one or more immunoglobulins are secreted in high amounts. www.healthoracle.org 1 Rouleaux formation can, however, be a normal physiological finding in horses, cats and pigs. When inflammation occurs the body produces proteins in the blood which make the red cells clump together. Heavier cell aggregates fall faster than normal red cells. For healthy individuals, the normal rate is up to 20 millimeters in one hour. Inflammation increases the rate significantly. Since inflammation can be caused by conditions other than arthritis, the sedrate test alone is not diagnostic. Sedrate can also point out to diseases involving other organs. Causes of a high ESR include: • • • • malignancy: o malignant lymphoma o carcinomas of colon and breast haematologic: o multiple myeloma - a high ESR plus osteoporosis equals multiple myeloma until proved otherwise o anaemia of acute or chronic disease, alone or combined with iron deficiency anaemia - not Fe deficiency alone o Macrocytosis elevates ESR. connective tissue disorders - especially: o systemic lupus erythematosus } normal in 5% of cases o rheumatoid arthritis } patients o polymyalgia rheumatica o temporal arteritis o systemic sclerosis infections: o tuberculosis o acute hepatitis o bacterial www.healthoracle.org 2 • others: o sarcoidosis o renal diseases - especially with azotemia o drug fever o hepatic cirrhosis o physiological increases in fibrinogen e.g. during pregnancy, also raise ESR levels The investigation of a patient with a high ESR and no clear explanation should include the following: • • • • • • • • • full blood count Immunoglobulin electrophoresis or Immunoglobulin fixation electrophoresis Electrolytes BUN Creatinine CRP Anti-CCP antibody radiography of the chest and abdomen biopsy (e.g. bone marrow, temporal artery) may be indicated Clinical Utility The erythrocyte sedimentation rate (ESR) determination is a commonly performed laboratory test with a time-honored role. However, the usefulness of this test has decreased as new methods of evaluating disease have been developed. The test remains helpful in the specific diagnosis of a few conditions, including temporal arteritis, polymyalgia rheumatica and, possibly, rheumatoid arthritis. It is useful in monitoring these conditions and may predict relapse in patients with Hodgkin’s disease. Use of the ESR as a screening test to identify patients who have serious disease is not supported by the literature. Some studies suggest that the test may be useful as a ‘sickness index’ in the elderly or as a www.healthoracle.org 3 screening tool for a few specific infections in certain settings. An extreme elevation of the ESR is strongly associated with serious underlying disease, most often infection, collagen vascular disease or metastatic malignancy. When an increased rate is encountered with no obvious clinical explanation, the physician should repeat the test after an appropriate interval rather than pursue an exhaustive search for occult disease. Physiologic Basis for the Test TABLE 1 Reference Ranges for the ESR in Healthy Adults Adults Upper limit of reference range (mm/hr) Age < 50 years Men Women Age > 50 years Men Women 0 to 15 0 to 20 0 to 20 0 to 30 The basal ESR is slightly higher in females. The widely used rule for calculating normal maximum ESR values in adults (98% confidence limit) is given by a formula devised in 1983. Children Normal values of ESR have been quoted as 1to 2 mm/hr at birth, rising to 4 mm/hr 8 days after delivery, and then to 17 mm/hr by day 14. Typical normal ranges quoted are: • Newborn: 0 to 2 mm/hr www.healthoracle.org 4 • Neonatal to puberty: 3 to 13 mm/hr, but some laboratories place an upper limit of 20. As with other laboratory tests, the actual reference range used for the ESR should be established by the laboratory performing the test. Women tend to have higher ESR values, as do the elderly. For unknown reasons, obese people have also been noted to have slightly elevated ESRs, although this is not thought to have clinical significance. Any condition that elevates fibrinogen (e.g., pregnancy, diabetes mellitus, end-stage renal failure, heart disease, collagen vascular diseases, malignancy) may also elevate the ESR. Anemia and macrocytosis increase the ESR. In anemia, with the hematocrit reduced, the velocity of the upward flow of plasma is altered so that red blood cell aggregates fall faster. Macrocytic red cells with a smaller surface-to-volume ratio also settle more rapidly. A decreased ESR is associated with a number of blood diseases in which red blood cells have an irregular or smaller shape that causes slower settling. In patients with polycythemia, too many red blood cells decrease the compactness of the rouleau network and artifactually lower the ESR. An extreme elevation of the white blood cell count as observed in chronic lymphocytic leukemia has also been reported to lower the ESR. Hypofibrinogenemia, hypergammaglobulinemia associated with dysproteinemia, and hyperviscosity may each cause a marked decrease in the ESR. Although it has been reported that drug therapy with aspirin or other nonsteroidal anti-inflammatory agents may decrease the ESR, this has been disputed. Because the ESR determination is frequently performed in office laboratories, careful attention to technical factors that may produce erroneous values is important (Table 2). A tilted ESR tube will cause an artifactual elevation, whereas inadequate anticoagulation with clotting of the blood sample will consume fibrinogen and may artifactually lower the ESR. www.healthoracle.org 5 Researchers have wondered whether other tests, such as measurement of C-reactive protein, may perform better than the ESR. Repeatedly, the ESR and plasma viscosity determinations have been shown to be the most satisfactory monitors of acute-phase response to disease after the first 24 hours. During the first 24 hours in an inflammatory process, C-reactive protein may be a better indicator of the acute phase response. However, C-reactive protein tests are more expensive, less widely available and more time-consuming to perform than the ESR. Advantages and disadvantages of these three tests are summarized in Table 3. TABLE 2 Factors That May Influence ESR Factors that increase ESR Old age Female Pregnancy Anemia Red blood cell abnormalities Macrycytosis Technical factors Dilutional problem Increased temperature of specimen Tilted ESR tube Elevated fibrinogen level Infection Inflammation Malignancy Factors that decrease ESR Extreme leukocytosis Polycythemia Red blood cell abnormalities Spherocytosis Acanthocytosis Microcytosis Technical factors Dilutional problem Inadequate mixing Clotting of blood sample Short ESR tube Vibration during testing Protein abnormalities Hypofibrinogenemia Hypogammaglobulinemia Dysproteinemia with hyperviscosity state Factors with no clinically significant effect or questionable effect Obesity Body temperature Recent meal Aspirin NSAIDs NSAIDs = nonsteroidal anti-inflammatory drugs; ESR = erythrocyte sedimentation rate. Using the ESR to Make a Diagnosis www.healthoracle.org 6 The ESR remains an important diagnostic criterion for only two diseases: polymyalgia rheumatica and temporal arteritis (Table 4). Polymyalgia rheumatica is characterized by severe aching and stiffness in the neck, shoulder girdle or pelvic girdle areas. In some patients, systemic symptoms may predominate, with initial manifestations including anemia, fever of unknown origin or a nonspecific systemic illness accompanied by anorexia, malaise and weight loss. Temporal arteritis is usually characterized by headaches, visual disturbances such as blindness, a tender, reddened or nodular temporal artery, facial pain and jaw claudication. Extra-cranial vasculitis sometimes is associated with temporal arteritis and may present with symptoms affecting the liver, kidneys or peripheral nervous system. Systemic manifestations including anemia, fever, weight loss, malaise and an abnormal alkaline phosphatase value are frequently present. Nearly all patients who have temporal arteritis will have an elevated ESR; however, an occasional patient may present with a normal value. One study found that the average ESR was greater than 90 mm per hour in patients who had temporal arteritis, with values exceeding 30 mm per hour in 99 percent of the cases. However, if there is solid clinical evidence of temporal arteritis, a normal ESR value should be disregarded, and the patient should undergo a temporal artery biopsy or an empiric trial of corticosteroid therapy. The ESR traditionally has been a diagnostic parameter for rheumatoid arthritis, but it is used as a means of staging the disease rather than as one of the major diagnostic criteria. The American Rheumatism Association criteria include an elevated ESR as one of 20 findings that may be present. Most rheumatologists believe that careful joint examination confirming synovitis constitutes a more important diagnostic criterion. However, the ESR may still be useful if the diagnosis is questionable and definite evidence of inflammation might affect therapeutic decisions. Monitoring disease activity or response to therapy www.healthoracle.org 7 TABLE 3 Comparison of the ESR, Creactive Protein and Plasma Viscosity Tests Test Advantages Disadvantages ESR Inexpensive, Affected by a quick, simple to variety of perform factors, including anemia and red blood cell size; not sensitive enough for screening CMost rapid Wide reference reactive response to range may protein inflammation necessitate (complementary sequential to ESR in this recording of regard) values, expensive, batch processing may delay individual results Plasma Unaffected by Expensive, not viscosity anemia or red widely blood cell size available, technically cumbersome to perform ESR = erythrocyte sedimentation rate. In the past, the ESR was commonly used as an index of disease activity in patients who had certain disorders. With the development of more specific methods of evaluation, the ESR has remained an appropriate measure of disease activity or response to therapy for only a few diseases: temporal arteritis, polymyalgia rheumatica, rheumatoid arthritis and, possibly, Hodgkin’s disease. www.healthoracle.org 8 In following the response to therapy in temporal arteritis and polymyalgia rheumatica, the ESR may not always give a clear indication of disease activity. Therefore, patients should be monitored by ESR values and clinical findings. For example, when corticosteroid therapy is started for temporal arteritis or polymyalgia rheumatica, the ESR usually drops within a few days. In many patients the ESR will stop at a higher-than-normal level, even if the patient’s clinical status has dramatically improved. For this reason, an elevated ESR in a patient who has established temporal arteritis or polymyalgia rheumatica should not be used as the sole rationale for maintaining or increasing steroid therapy if the patient is doing well clinically. The converse is also true, because clinical relapse can occur in the face of a normal ESR finding. In rheumatoid arthritis, the ESR tends to reflect clinical disease activity but usually mirrors other symptoms such as morning stiffness or fatigue. Joint examination is considered more useful in assessing synovitis. In one study, the ESR level that best distinguished patients with rheumatoid arthritis in remission from those with active disease was less than 20 mm per hour for men and less than 30 mm per hour for women. However, other studies have shown that a significant proportion of patients in clinical remission may still have an elevated ESR value. Cancer In oncology, a high ESR has been found to correlate with overall poor prognosis for various types of cancer, including Hodgkin’s disease, gastric carcinoma, renal cell carcinoma, chronic lymphocytic leukemia, breast cancer, colorectal cancer and prostate cancer. In patients with solid tumors, a sedimentation rate greater than 100 mm per hour usually indicates metastatic disease, but for most tumors this relatively nonspecific finding has been supplanted by more precise diagnostic tests. However, European studies of patients with Hodgkin’s disease have suggested that an elevated ESR may still be an excellent predictor of early relapse, especially if the value remains elevated after www.healthoracle.org 9 chemotherapy or fails to drop to a normal level within six months after therapy. Certainly, an increased ESR should never be used as the sole criterion for diagnosing relapsed Hodgkin’s disease. Discriminating Iron Deficiency from Anemia of Chronic Disease TABLE 4 Utility of the ESR: Key Considerations • • • • • • • • www.healthoracle.org The ESR is an inexpensive, simple test of chronic inflammatory activity. Indications for the ESR have decreased as the sophistication of laboratory testing has increased. The ESR rises with age, but this increase may simply reflect a higher disease prevalence in the elderly. The use of the ESR as a screening test in asymptomatic persons is limited by its low sensitivity and specificity. An elevated ESR is a key diagnostic criterion for polymyalgia rheumatica and temporal arteritis, but normal values do not preclude these conditions. When there is a moderate suspicion of disease, the ESR may have some value as a "sickness index." An extremely elevated ESR (>100 mm/hr) will usually have an apparent cause--most commonly infection, malignancy or temporal arteritis. A mild to moderately elevated ESR without obvious etiology should prompt repeat testing after several months rather than 10 an expensive search for occult disease. ESR = erythrocyte sedimentation rate. The ESR may be useful in differentiating iron deficiency from anemia of chronic disease in patients with a background chronic inflammatory condition such as rheumatoid arthritis. Iron deficiency anemia and anemia of chronic disease are hypo-regenerative and characterized by a low reticulocyte count. Unfortunately, neither iron studies nor serum ferritin levels are definitive in distinguishing between these two types of anemia. Because both may have a transferrin saturation of around 15 percent, simply evaluating the serum iron level and percent saturation will not differentiate between the two conditions. Similarly, an individual serum ferritin level may not be helpful when inflammation is present because ferritin is an acute phase reactant and may be artifactually elevated. Screening for Systemic Disease or Neoplasia Unfortunately, the ESR is neither sensitive nor specific when used as a general screening test. For instance, the ESR may be elevated in the presence of infectious disease, other inflammatory or destructive processes, collagen vascular disease or malignancy, but it may not be increased in a number of infectious diseases (e.g., typhoid fever, malaria, mononucleosis), allergic processes, angina (as opposed to myocardial infarction) or peptic ulcer disease (as opposed to active inflammatory bowel disease). Because an elevated ESR may occur in so many different clinical settings, this finding is meaningless as an isolated laboratory value. In addition, some patients who have malignant tumors, infections or other inflammatory disorders will have normal ESR values. Most unexplained ESR elevations are short-lived and not associated with any www.healthoracle.org 11 specific underlying process. In those instances where disease is present, it will usually be obvious after completion of history taking, physical examination and collection of routine laboratory data. Although an elevated ESR may occur with many types of cancer, it rarely indicates an occult tumor because most of these patients have widely metastatic disease. For this reason, when a mild to moderate elevation of the ESR (less than 100 mm per hour) is encountered in an asymptomatic patient, simply repeating the test at some future time should be considered in the absence of other clinical findings. No evidence suggests that an elevated ESR that is unsubstantiated by history, physical examination or other findings should trigger an extensive laboratory or radiographic work-up or invasive diagnostic procedures. Screening for Infection in Specific Clinical Settings Recent studies have evaluated the ESR as a screening test for infection in specific clinical instances such as infection associated with orthopedic prostheses, pediatric bacterial infection and gynecologic inflammatory disease. Although frequently abnormal in patients who have an infected prosthesis, the ESR value is not as sensitive or specific an indicator of infection as joint aspiration. Elevation of the ESR has been proposed as a clue to the presence of an invasive bacterial infection in children after the first 48 hours of symptoms. In one investigation, the ESR more accurately indicated the severity of acute pelvic inflammatory disease than did the physical examination, thus helping to evaluate patients who required antimicrobial therapy. The appropriateness of the ESR as a screening test for infection, even in these well-defined clinical settings, requires further evaluation. Usefulness as a sickness index in the elderly Some authors have proposed that the ESR be used as an inexpensive ‘sickness index’ in the elderly. In a study of 142 residents of a longwww.healthoracle.org 12 term care hospital who had a nonspecific change in health status or developed new musculoskeletal complaints, the post-test probability of new disease rose from 7 percent in those with an ESR of less than 20 mm per hour to 66 percent in those with an ESR of more than 50 mm per hour. However, this investigation specifically excluded patients known to have an ESR-elevating disease and those in whom no disease was suspected. The authors concluded that combining clinical evaluation with an individual ESR value allowed the identification of groups of patients in whom the likelihood of disease was quite low or reasonably high, possibly limiting unnecessary investigations. Elevated ESRs, while more prevalent in the elderly than in younger individuals, have a similar pathological significance. But as clinical conditions in the elderly are usually obscure, we should be more careful to investigate the issue of high ESR in geriatric population, even when they are asymptomatic. Extreme Elevation of the ESR An extreme elevation of the ESR (defined as greater than 100 mm per hour) is associated with a low false-positive rate for a serious underlying disease. The conditions found in this situation have varied in individual populations, depending on patient age and inpatient versus outpatient status. In most series, infection has been the leading cause of an extremely elevated value, followed by collagen vascular disease and metastatic malignant tumors. Renal disease has also been a notable etiologic factor. Because most of these conditions are clinically apparent, any tests performed should be clinically driven. For instance, if symptoms of infection are present, the appropriate cultures, including urine and blood, and skin testing for tuberculosis should be obtained. An exhaustive search for an occult malignancy should not be undertaken because, if cancer is present, it is almost always metastatic. www.healthoracle.org 13 No obvious cause is apparent in fewer than 2 percent of patients with a markedly elevated ESR. In such patients, the history and physical examination coupled with readily available tests will usually establish the etiology. Because a notable number of patients with an ESR greater than 100 mm per hour have myeloma or some other type of dysproteinemia, urine and serum protein electrophoretic studies should be included in the testing. Relation to C-reactive protein C-reactive protein is an acute phase protein that is produced by the liver during an inflammatory reaction. Since C-reactive protein levels in the blood rise more quickly after the inflammatory or infective process begins, ESR is often replaced with C-reactive protein measurement. There are specific drawbacks, however, as they were found to be independently associated with a diagnosis of acute maxillary sinusitis so that the combination of the two measurements improved diagnostic sensitivity and specificity. www.healthoracle.org 14